- Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials
- Large investment of £10m from Oxford Sciences Innovation
- Further programs include vaccines to boost cancer immunotherapies
Oxford spin out company Vaccitech has launched today with £10m seed investment to develop a universal flu vaccine already showing promise in clinical trials. The company is also developing and testing other vaccines which trigger the immune response needed to prevent or treat a range of serious diseases.
Read more (ISIS Innovation website)